PureTech Health

From Wikipedia, the free encyclopedia

PureTech Health

Company type	Public
Traded as	LSE: PRTC
Industry	Healthcare
Founded	2005
Headquarters	Boston, United States
Key people	Christopher Viehbacher (Chairman) Daphne Zohar (CEO)
Products	Medicines
Revenue	$3.3 million (2023)^[1]
Operating income	$(146.2) million (2023)^[1]
Net income	$(66.6) million (2023)^[1]
Website	puretechhealth.com

PureTech Health is a biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

History

[edit]

The company was founded by Daphne Zohar, an American entrepreneur, in 2005.^[2] It was the subject of an initial public offering on the London Stock Exchange in June 2015.^[3]

Operations

[edit]

Companies which PureTech Health founded include Karuna Pharmaceuticals,^[4] Gelesis, which has received FDA approval as a treatment for weight management,^[5] Akili Interactive Labs, which is developing a digital therapeutic platform for cognitive disorders,^[6] Vedanta Biosciences, which is developing drugs to treat autoimmune and inflammatory diseases,^[7] and Follica which is developing new treatments for androgentic alopecia among others.^[8] PureTech also has a pipeline of its own immunology, lymphatic and oncology based therapeutics.^[9]

References

[edit]

^ ^a ^b ^c "Annual Results 2023". PureTech Health. Retrieved 26 April 2024.
^ "PureTech's long view on biopharma". Boston Globe. 26 August 2015. Archived from the original on 16 August 2019. Retrieved 16 August 2019.
^ "PureTech banks $171M in a London IPO to fund its biotech bets". Fierce Biotech. 19 June 2015. Archived from the original on 16 August 2019. Retrieved 16 August 2019.
^ "PureTech Health surges as Karuna investment rockets 442%". Proactive Investors. 19 November 2019. Archived from the original on 14 December 2019. Retrieved 14 December 2019.
^ "Gelesis raises $12 million for pill that staves off hunger". BetaBoston.com. May 16, 2014. Archived from the original on August 3, 2014. Retrieved December 14, 2019.
^ "Akili Interactive adds $13 million to Series C funding pool". The Pharma Letter. 9 August 2018. Archived from the original on 14 December 2019. Retrieved 14 December 2019.
^ "PureTech Health affiliate Vedanta Biosciences awarded $5.8m grant". Sharecast. 5 December 2019. Archived from the original on 14 December 2019. Retrieved 14 December 2019.
^ "Positive Results From PureTech Affiliate Male Pattern Hair Loss Study". Morning Star. 13 June 2019. Archived from the original on 1 March 2020. Retrieved 14 December 2019.
^ "PureTech Licenses Glyph Lymphatic Technology". FT. 29 August 2017. Archived from the original on 15 January 2020. Retrieved 14 December 2019.

External links

[edit]

Official website

FTSE 100 ← FTSE 250 companies of the United Kingdom → FTSE SmallCap

Retrieved from "https://en.wikipedia.org/w/index.php?title=PureTech_Health&oldid=1220945225"

Categories: